ARTICLE | Clinical News
Tesetaxel: Phase II started
May 14, 2012 7:00 AM UTC
Genta began the double-blind, placebo-controlled, international Phase II TESEGAST trial to compare 27 mg/m 2 oral tesetaxel on day 1 of a 21-day cycle in combination with Xeloda capecitabine vs. Xelo...